enGene Therapeutics Inc. Warrants Stock Performance

Open N/A	Prev. Close N/A	Circuit Range N/A
Day Range N/A	Year Range N/A	Volume N/A
Average Traded N/A

enGene Therapeutics Inc. Warrants Share Price Chart

$0.00$0.00

enGene Therapeutics Inc. Warrants Quarterly Profit & Loss

All figures in USD

Particulars	Apr 2024	Jul 2024	Jan 2025	Apr 2025	Jul 2025	Jan 2026
Revenue	N/A	N/A	N/A	N/A	N/A	N/A
Net Profit	-$14.98M	-$14.15M	-$24.62M	-$25.82M	-$28.99M	-$29.75M
Net Profit Margin	N/A	N/A	N/A	N/A	N/A	N/A
Income Change	N/A	5.58%	-73.99%	-4.87%	-12.30%	-2.62%

enGene Therapeutics Inc. Warrants Annual Profit & Loss

All figures in USD

Particulars	2023	2025
Revenue	N/A	N/A
Net Profit	-$99.92M	-$117.30M
Net Profit Margin	N/A	N/A
Income Change	N/A	-17.40%

About enGene Therapeutics Inc. Warrants

enGene Holdings Inc., through its subsidiary enGene, Inc., operates as a clinical-stage biotechnology company that develops genetic medicines to help patients suffering from bladder cancer. Its lead product candidate is detalimogene voraplasmid, a non-viral monotherapy to treat non-muscle invasive bladder cancer (NMIBC) with carcinoma in situ (CIS) in patients that have been unresponsive to treatment with Bacillus Calmette-Guérin (BCG). enGene Holdings Inc. is based in Montreal, Canada.

enGene Therapeutics Inc. Warrants Historical Returns

Month	Open	Close	Change %

ENGNW Share Price FAQs

What is enGene Therapeutics Inc. Warrants share price today?

enGene Therapeutics Inc. Warrants share price today is $0.00 as on August 30, 2026 at 1:21 pm IST.

What is the 52 week high and 52 week low of enGene Therapeutics Inc. Warrants stock?

52 week high/low data for enGene Therapeutics Inc. Warrants is currently unavailable.

What is ENGNW's net income for the last quarter?

ENGNW's net income for the last quarter is -0.03B USD.

Can I buy ENGNW shares in India?

Yes. You can buy ENGNW in India by opening an international trading account.